Schizophrenia, Paranoid: Clinical Trials

41 trials for Schizophrenia, Paranoid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 7 unknown, 5 recruiting, 2 terminated. 23 Not applicable, 5 Phase 2, 5 Phase 4, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable23Completed 14, Unknown 4, Recruiting 3, Not yet recruiting 1, Terminated 1
Phase 25Completed 3, Enrolling by invitation 1, Unknown 1
Phase 45Completed 5
Phase 33Completed 2, Unknown 1

Follow Schizophrenia, Paranoid: new trials by email Literature Review of Schizophrenia, Paranoid trials Research Report on Schizophrenia, Paranoid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shared Decision Making for Antipsychotic Medications
The Antipsychotic Medication Decision Aid (APM-DA) - Schizophrenia, Schizoaffective Disorder
Not applicableNot yet recruitingNew York State Psychiatric Institute1202027-01-012026-03-30
Enhancing Veteran-Clinical Collaboration in VA PRRCs
Collaborative Decision Skills Training, Leveling Up - Schizophrenia, Schizoaffective Disorder
Not applicableRecruitingVA Office of Research and Development1192026-08-122026-08-19
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
FEEL GOOD, Treatment as Usual (TAU) - Delusional Disorder, Brief Psychotic Disorder
Not applicableRecruitingStephanie Mehl2522026-05-272026-09-22
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities
SUCCEED Community-Based Intervention - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedLondon School of Hygiene and Tropical Medicine4252025-09-182026-06-08
Young Adults With Violent Behavior During Early Psychosis (Aim 2)
adapted behavioral intervention - Schizophrenia, Schizo Affective Disorder
Not applicableCompletedColumbia University122024-03-192026-10-05
Tau Biomarkers in Late-onset Psychosis (LOP)
Tau PET imaging scan - Late Onset Schizophrenia, Delusional Disorder (Late Onset)
RecruitingJeremy Koppel162024-02-162025-09-29
The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care
Metacognitive Skills Training (MCT), Treatment as usual - Schizophrenia, Schizoaffective Disorder
Not applicableRecruitingUniversity of Jyvaskyla852023-09-012024-05-14
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia
RecruitingBeth Israel Deaconess Medical Center3202023-01-012026-03-10
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
Cognitive Remediation (REHACOP), Metacognitive Training (MCT) - Schizophrenia, Schizophreniform Disorders
Not applicableUnknownUniversitat Autonoma de Barcelona1602022-09-012024-05-23
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness
Collaborative Decision Skills Training, Leveling Up - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedVA Office of Research and Development392022-07-052025-12-26
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
Rituximab - Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior
Phase 2Enrolling by invitationUppsala University Hospital402022-05-012024-11-19
Feasibility of a Novel Process-based Treatment for Patients With Psychosis
Metacognitive and Defusion Training - Schizophrenia, Schizotypal Disorder
Not applicableCompletedMax-Planck-Institute of Psychiatry372021-05-102023-10-23
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis
OPUS YOUNG, Treatment as Usual - Schizophrenia, Schizotypal Disorder
Not applicableCompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2842021-05-062026-08-20
Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".
Cognitive Behavioural Virtual Reality Therapy., Traditional Cognitive Behavioural Therapy - Paranoid Schizophrenia, Schizophrenia and Related Disorders
Not applicableCompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2592021-04-092026-08-12
Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders
Individual cognitive stimulation therapy (iCST) - Psychotic Disorders, Schizophrenia
Not applicableCompletedCEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas382021-03-292022-03-10
Quantitative Investigation of Environment and Participation
No Intevention Used - Supported Accommodation Residents, Schizophrenia, Shizotypal and Delusional Disorders
UnknownQueen Margaret University2352020-01-172019-10-02
The Efficacy of Using a Smartphone App to Support Shared Decision Making in People With a Diagnosis of Schizophrenia
Momentum app - Schizophrenia, Schizotypal and Delusional Disorders
Not applicableCompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1942019-01-072022-04-08
Research Into Antipsychotic Discontinuation and Reduction Trial
Antipsychotic Reduction, Antipsychotic Maintenance - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedUniversity College, London2532016-03-242022-05-23
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine, Placebo, Cognitive Behavioral Therapy - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedNYU Langone Health582014-02-012020-03-25
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
CBT-E, Treatment as Usual - Schizophrenia, Delusional Disorder
Not applicableCompletedPhilipps University Marburg642014-01-012020-03-04

Showing 20 of 41. Sign in to see all of them.

Narrower conditions

Schizophrenia (39)  ·  Psychotic Disorders (28)  ·  Mental Disorders (7)  ·  Bipolar Disorder (5)  ·  Delusions (4)  ·  Schizophrenia, Disorganized (4)  ·  Schizotypal Personality Disorder (4)  ·  Depressive Disorder, Major (3)  ·  Disorders of Sex Development (2)  ·  Emotional Regulation (2)  ·  Mania (2)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (2)  ·  Schizophrenia, Catatonic (2)  ·  Acquired Immunodeficiency Syndrome (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (39)  ·  Mental Disorders (34)  ·  Behavior (11)  ·  Behavioral Symptoms (6)  ·  Bipolar and Related Disorders (5)  ·  Mood Disorders (5)  ·  Nervous System Diseases (4)  ·  Personality Disorders (4)  ·  Social Behavior (4)  ·  Depressive Disorder (3)  ·  Endocrine System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)

Interventions

Therapeutics (4)  ·  Cognitive Behavioral Therapy (3)  ·  Cycloserine (2)  ·  asenapine (2)  ·  Acceptance and Commitment Therapy (1)  ·  Benztropine (1)  ·  Cognitive Remediation (1)  ·  Delivery of Health Care, Integrated (1)  ·  MK-0249 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Myo-Inositol-1-Phosphate Synthase (1)  ·  Olanzapine (1)  ·  Palliative Care (1)  ·  Risperidone (1)  ·  Rituximab (1)

Sponsors

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (4)  ·  Centre for Addiction and Mental Health (2)  ·  Merck Sharp & Dohme LLC (2)  ·  Organon and Co (2)  ·  Philipps University Marburg (2)  ·  VA Office of Research and Development (2)  ·  AstraZeneca (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas (1)  ·  Central Institute of Mental Health, Mannheim (1)  ·  Columbia University (1)  ·  German Research Foundation (1)  ·  Hospital Authority, Hong Kong (1)  ·  Jeremy Koppel (1)  ·  London School of Hygiene and Tropical Medicine (1)

Countries

United States (11)  ·  Germany (10)  ·  Denmark (4)  ·  Canada (2)  ·  United Kingdom (2)  ·  Brazil (1)  ·  China (1)  ·  Finland (1)  ·  Malawi (1)  ·  Nigeria (1)  ·  Portugal (1)  ·  Sierra Leone (1)  ·  Spain (1)  ·  Sweden (1)  ·  Zimbabwe (1)

Top investigators

Emily Treichler, PhD (2)  ·  Ana Barajas Velez (1)  ·  Ana E Marques Castro, M.Sc. (1)  ·  Andreas Bechdolf, PD Dr. (1)  ·  Andreas Bechdolf, Prof. Dr. (1)  ·  Anne K Pagsberg, PhD (1)  ·  Ariel Graff, MD (1)  ·  Ariel Graff-Guerrero, MD,PhD (1)  ·  Bent Nielsen, Professor (1)  ·  David C. Mamo, MD MSc (1)  ·  Dena Stoner (1)  ·  Donald C Goff, MD (1)  ·  Donald C. Goff, MD (1)

Results publications

PMID 26091193, PMID 20048350, PMID 21723096, PMID 23523692, PMID 24062154, PMID 24062155, PMID 25188752, PMID 26093636, PMID 26714845, PMID 27557949, PMID 28086010, PMID 28778554, PMID 29485988, PMID 31208376, PMID 31483451, PMID 31708810, PMID 31814102, PMID 32507378, PMID 33781352, PMID 36076205, PMID 36287604, PMID 37778356, PMID 38840160, PMID 40804323, PMID 41654084, PMID 42037481, PMID 42531158

NIH funding

2009 (2), 2019 (1), K23MH126312 (1), P50MH060450 (1), R01MH127174 (1), R21MH135148 (1)